Citadel Advisors
DH icon

Citadel Advisors’s Definitive Healthcare DH Stock Holding History

Citadel Advisors’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,800
Closed -$19.7K – 13025
2025
Q1 		$19.7K Buy
6,800
+2,600
+62% +$10.6K ﹤0.01% 13158
2024
Q4 		$17.3K Sell
4,200
-1,400
-25% -$6.12K ﹤0.01% 13262
2024
Q3 		$25K Buy
5,600
+4,900
+700% +$23K ﹤0.01% 12600
2024
Q2 		$3.82K Sell
700
-4,300
-86% -$27.1K ﹤0.01% 13545
2024
Q1 		$40.4K Sell
5,000
-400
-7% -$3.54K ﹤0.01% 12385
2023
Q4 		$53.7K Sell
5,400
-11,700
-68% -$91.8K ﹤0.01% 11711
2023
Q3 		$137K Sell
17,100
-6,100
-26% -$61.3K ﹤0.01% 10498
2023
Q2 		$255K Buy
23,200
+12,400
+115% +$128K ﹤0.01% 9366
2023
Q1 		$112K Buy
10,800
+10,600
+5,300% +$125K ﹤0.01% 11095
2022
Q4 		$2.2K Buy
+200
New +$2.57K ﹤0.01% 14370

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors's DH Position: Q1 2026 in Review

Citadel Advisors increased its Definitive Healthcare (DH) stake by 49% in Q1 2026, buying an estimated $249K and bringing the position to 433,408 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #9145.

Citadel Advisors first reported a position in DH in Q3 2021 and has held it in 15 quarters since. The position peaked at $23.2M in Q3 2021. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Citadel Advisors held 433,408 shares of Definitive Healthcare worth $533K as of Q1 2026.
  • Citadel Advisors bought 143,108 Definitive Healthcare shares in Q1 2026, an estimated $249K.
  • Definitive Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9145 holding.
  • Citadel Advisors first reported a position in Definitive Healthcare in Q3 2021 and has held it in 15 quarters since.
  • Citadel Advisors's Definitive Healthcare position peaked at $23.2M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.